Pascal Soriot. AP Images
November 6, 2019 07:02 AM ESTUpdated 08:02 AM
Financing
China

As­traZeneca sketch­es plans for a $1B ven­ture fund — and it's go­ing to Chi­na

Amber Tong

Go­ing down an in­creas­ing­ly trod­den path to the world’s sec­ond largest health­care mar­ket, As­traZeneca is help­ing set up a life sci­ences fund to groom Chi­na …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times